Suppr超能文献

类固醇在心脏手术中的保护作用:随机双盲试验的荟萃分析。

Protective effects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials.

机构信息

Division of Cardiac Surgery, Department of Emergency and Organ Transplant, University of Bari, Bari, Italy.

出版信息

J Cardiothorac Vasc Anesth. 2011 Feb;25(1):156-65. doi: 10.1053/j.jvca.2010.03.015. Epub 2010 May 26.

Abstract

OBJECTIVE

Cardiac surgery and cardiopulmonary bypass (CPB) induce an acute inflammatory response contributing to postoperative morbidity. The use of steroids as anti-inflammatory agents in surgery using CPB has been tested in many trials and has been shown to have good anti-inflammatory effects but no clear clinical advantages for the lack of an adequately powered sample size. The aim of this study was to evaluate the effects of steroid treatment on mortality and morbidity after cardiac surgery.

DESIGN

A systematic meta-analysis of randomized double-blind trials (RDBs).

SETTING

A university hospital.

PARTICIPANTS

Adult patients who underwent cardiac surgery.

MEASUREMENTS AND MAIN RESULTS

A trial search was performed through PubMed and Cochrane databases from 1966 to January 2009. Among 104 clinical trials reviewed, 31 RDB trials (1,974 patients) were considered suitable to be analyzed. A quality assessment of the trials was performed using the Jadad score. The types of steroid used in these trials were methylprednisolone (51.4%), dexamethasone (34.3%), hydrocortisone (5.7%), prednisolone (2.9%), or a combination of methylprednisolone and dexamethasone (5.7%). Steroid prophylaxis provided a protective effect preventing postoperative atrial fibrillation (odds ratio = 0.56; confidence interval [CI] 0.44-0.72, p < 0.0001), reducing postoperative blood loss (mean difference = -204.2 mL; CI from -287.4 to -121 mL; p < 0.0001), and reducing intensive care unit (mean difference = -6.6 hours; CI from -10.5 to -2.7 hours, p = 0.0007) and overall hospital stay (mean difference = -0.8 days; CI from -1.4 to -0.2 days, p = 0.01). Steroid prophylaxis had no effect on postoperative mortality, mechanical ventilation duration, re-exploration for bleeding, and postoperative infection.

CONCLUSIONS

A systematic review of RDB trials reveals that steroid prophylaxis may reduce morbidity after cardiac surgery and does not increase the risk of postoperative infections.

摘要

目的

心脏手术和心肺转流术(CPB)会引起急性炎症反应,导致术后发病率增加。在使用 CPB 的心脏手术中使用类固醇作为抗炎药物已经在许多试验中进行了测试,并且已经显示出良好的抗炎作用,但由于缺乏足够大的样本量,没有明显的临床优势。本研究旨在评估类固醇治疗对心脏手术后死亡率和发病率的影响。

设计

随机双盲试验(RDB)的系统荟萃分析。

地点

一所大学医院。

参与者

接受心脏手术的成年患者。

测量和主要结果

通过 PubMed 和 Cochrane 数据库从 1966 年到 2009 年 1 月进行了试验搜索。在审查的 104 项临床试验中,有 31 项 RDB 试验(1974 名患者)被认为适合进行分析。使用 Jadad 评分对试验进行质量评估。这些试验中使用的类固醇类型为甲泼尼龙(51.4%)、地塞米松(34.3%)、氢化可的松(5.7%)、泼尼松龙(2.9%)或甲泼尼龙和地塞米松的组合(5.7%)。类固醇预防可提供保护作用,预防术后心房颤动(优势比=0.56;置信区间[CI]0.44-0.72,p<0.0001),减少术后失血(平均差值=-204.2 mL;CI 从-287.4 到-121 mL;p<0.0001),并减少重症监护病房(平均差值=-6.6 小时;CI 从-10.5 到-2.7 小时,p=0.0007)和总住院时间(平均差值=-0.8 天;CI 从-1.4 到-0.2 天,p=0.01)。类固醇预防对术后死亡率、机械通气时间、因出血再次探查以及术后感染无影响。

结论

对 RDB 试验的系统评价表明,类固醇预防可能减少心脏手术后的发病率,并且不会增加术后感染的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验